Percentage of all eligible carcinoma and carcinosarcoma of the endometrium specimens for which all required data elements of the Cancer Protocol are included AND meet the maximum 4 business day turnaround time (TAT) requirement (Report Date - Accession Date <= 4 business days). INSTRUCTIONS: This measure has two performance rates that contribute to the overall performance score: 1. Percent of cases for which all required data elements of the cancer protocol are included. 2. Percent of cases that meet the maximum 4 business day turnaround time. The overall performance score submitted is a weighted average of: (Performance rate 1 x 70%)+(Performance rate 2 x 30%).